In this field, the earliest keywords include beta-2 glycoprotein I (beta2GPI) and thrombin generation, while ischemia reperfusion injury, ischemic stroke and coronary artery disease are the latest research targets. This evidence concerns the gene APOH and coronary artery disorder.